Upgrade to SI Premium - Free Trial

Boston Scientific (BSX) Says New Four-Year Data Demonstrate Rezum Water Vapor Therapy Offers Significant Durable Improvement of BPH Symptoms

January 25, 2019 6:47 AM
Boston Scientific Corporation (NYSE: BSX) today announced that data from a randomized clinical trial demonstrate that Rezūm™ Water Vapor Therapy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles